TransMedics Group, Inc.
Nasdaq · Electromedical & Electrotherapeutic Apparatus
Company Overview
A concise company profile alongside the latest public filing activity.
TransMedics Group develops organ care technology used to preserve and transport donor hearts, lungs, and livers for transplantation, including its Organ Care System (OCS) platform and related logistics services that keep organs functioning outside the body during transport.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| TOBIN JAMES RDirector | Sell | $6K | 59at $93.96 | Nov 9, 2026 |
| TOBIN JAMES RDirector | Sell | $380K | 4,000at $94.98 | Nov 9, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TMDX activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.